EXCELLABIO LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Phase 2
Terminated
- Conditions
- Gastric CancerOvarian CancerBreast Cancer Female
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- ExcellaBio LLC
- Target Recruit Count
- 5
- Registration Number
- NCT03342417
- Locations
- 🇺🇸
Hoffman Oncology, Bronx, New York, United States
News
No news found